文献速递泌尿生殖腹部MR

前列腺癌MRI引导局灶激光消融术后的MRI表现

MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer.
PubMed 文献 · AJR Am J Roentgenol · 2018-07-11

本研究纳入27例T1c-T2a期、Gleason评分≤7的前列腺癌患者,观察MRI引导局灶激光消融术前、术后即刻及术后3、12个月的多参数MRI表现,并与活检结果对照。消融后即刻消融区呈乏血供缺损,术后3个月以斑片状或带状T2信号减低最常见(66.7%),12个月以T2瘢痕最常见(66.7%);12个月时10例发现肿瘤复发,3例消融部位活检为持续性癌,所有活检阳性病例均表现为T2和ADC上边界清楚的结节状中等信号。

要点

  • 消融后即刻MRI示消融区乏血供缺损,为术后早期最可靠的消融区定位征象。
  • 术后3个月斑片状或带状T2信号减低见于66.7%消融灶,12个月T2瘢痕见于66.7%消融灶。
  • 活检阳性病例均表现为T2和ADC上边界清楚的结节状中等信号,2例伴消融区局灶强化。

核心结论

  • 多参数MRI可显示前列腺局灶激光消融术后的变化,可能成为监测MRI引导局灶激光消融术后患者的有价值工具。

研究设计与样本

  • 研究纳入27例符合入选标准并签署知情同意的患者,入选标准包括临床分期T1c-T2a、Gleason评分≤7、消融前后均行前列腺穿刺活检、消融前及消融后即刻和消融后3、12个月均行MRI。

关键影像表现/征象

  • 消融后即刻MRI示消融区乏血供缺损。
  • 术后3个月斑片状或带状T2信号减低见于66.7%的消融灶,术后12个月T2瘢痕见于66.7%的病灶。
  • 术后3个月斑片状或带状ADC信号减低及瘢痕样改变见于50.0%的病灶,术后12个月这些征象仍是最常见表现(27.8%的病灶)。
  • 所有消融后活检阳性病例均表现为T2和ADC上边界清楚的结节状中等信号。
  • 活检阳性的患者中2例可见消融区局灶强化。

诊断标准与关键数值

  • 术后12个月10例患者发现肿瘤复发,其中3例消融部位活检为持续性癌。
  • 活检阳性病例的影像学特征为T2和ADC上边界清楚的结节状中等信号。

临床应用与阅片要点

  • 消融后即刻MRI可用于确认消融区乏血供缺损的范围。
  • 术后3个月和12个月应关注消融区T2和ADC信号变化,斑片状或带状T2信号减低、ADC信号减低及瘢痕样改变为常见术后表现。
  • 活检阳性的复发或持续癌灶在T2和ADC上呈边界清楚的结节状中等信号,2例伴消融区局灶强化。
  • 随访中消融部位正向容积转运常数显著降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to describe the quantitative and qualitative findings of multiparametric prostate MRI performed after MRI-guided focal laser ablation of prostate cancer.

MATERIALS AND METHODS: A total of 27 consenting patients met the study inclusion criteria, which included but were not limited to the presence of clinical category T1c-T2a prostate cancer with a Gleason score of 7 or less, having undergone prostate biopsy before and after focal laser ablation, and having undergone MRI before ablation, immediately after ablation, and 3 and 12 months after ablation. Signal changes were evaluated both qualitatively and quantitatively and were then correlated with the results of subsequent biopsy performed at 3 and 12 months after ablation.

RESULTS: MRI performed immediately after ablation revealed a hypovascular defect in the ablation zone, with patchy or bandlike decreased T2 signal most commonly noted at 3 months (in 66.7% of ablated lesions) and T2 scarring observed in most lesions (66.7%) at 12 months. Patchy or bandlike decreased apparent diffusion coefficient signal and scarlike changes were most prevalent at 3 months after ablation (50.0% of lesions), and these features remained the most commonly observed findings at 12 months after ablation (27.8% of lesions). At 12 months after ablation, 10 patients were found to have recurrent tumor, with three patients found to have persistent cancer when biopsy was performed at the ablation site. All postablation biopsy cases with positive results showed suspicious T2 and apparent diffusion coefficient characteristics, which were considered to be a well-defined nodular intermediate signal on both of these sequences. Two of the patients for whom positive biopsy findings were noted had focal enhancement of the ablation zone. A significant reduction in the forward volume transfer constant after ablation was found at the ablation site on follow-up examination.

CONCLUSION: Multiparametric MRI can reveal postablation changes in the prostate and can be a valuable tool for monitoring patients who have undergone MRI-guided focal laser ablation.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Westin C, Chatterjee A, Ku E, et al. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer. AJR Am J Roentgenol. 2018. PMID: 29995499. doi:10.2214/AJR.17.19201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。